Drugs / avocado-soybean unsaponifiable
avocado-soybean unsaponifiable
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01062737 | Dec 1999 → Sep 2006 | osteoarthritis, hip | Laboratoires Expanscience S.A. | Completed | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | avocado-soybean unsaponifiable | “Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study.” PMID 23345601 ↗ Jan 2013 |
| Known as | ASU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01062737 ↗ |
| Known as | ASU-E | “OBJECTIVE: To assess the ability of avocado-soybean unsaponifiable-Expanscience (ASU-E) to slow radiographic progression in symptomatic hip osteoarthritis (OA).” PMID 23345601 ↗ Jan 2013 |
| Known as | avocado-soybean unsaponifiable-Expanscience | “OBJECTIVE: To assess the ability of avocado-soybean unsaponifiable-Expanscience (ASU-E) to slow radiographic progression in symptomatic hip osteoarthritis (OA).” PMID 23345601 ↗ Jan 2013 |
| Known as | Piascledine | “Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study.” PMID 23345601 ↗ Jan 2013 |